Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2020 / 04:00PM GMT
Release Date Price: €92.96 (+2.50%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. Good afternoon and good morning. I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo. Welcome to our 2020 Virtual Health Care Conference. With us, we have the management team from Tandem Diabetes, John Sheridan, the CEO; and Leigh Vosseller, the CFO. The format is going to be fireside chat for 30 minutes. We're going to try to get one audience poll question in here. So John and Leigh, thanks so much for joining us.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Thanks for having us, Larry.

Leigh A. Vosseller
Tandem Diabetes Care, Inc. - Executive VP, CFO & Treasurer

Thank you.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Great. So I wanted to start at a high level. First, with the strategy. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot